Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India

Table 2

Initial and final clinical cure rates by analysis population.

Analysis population	Initial clinical cure rate % (95% CI)	Final clinical cure rate % (95% CI)
Efficacy-evaluable population (𝑁=479)	99.6% (98.5–99.9)	94.2% (91.7–96.1)
Intent-to-treat population (𝑁=494)	98.4% (96.8–99.3)	91.5% (88.7–93.8)

CI, confidence interval.